Dis-Chem Pharmacies Limited (DCP.JO)
ZAc 3675.0
(-0.11%)
ZAc 3675.0
(-0.11%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 36.28 Billion | 32.66 Billion | 30.4 Billion | 26.27 Billion | 23.98 Billion | 21.42 Billion |
| Cost of Revenue | 29.12 Billion | 25.07 Billion | 23.57 Billion | 20.44 Billion | 18.42 Billion | 16.19 Billion |
| Gross Profit | 7.15 Billion | 7.58 Billion | 6.83 Billion | 5.83 Billion | 5.55 Billion | 5.22 Billion |
| Operating Expenses | 6.43 Billion | 5.79 Billion | 5.19 Billion | 4.57 Billion | 4.3 Billion | 4.03 Billion |
| Selling, General and Administrative Expenses | 1.23 Billion | 789.9 Million | 572.38 Million | 4.96 Billion | 4.04 Billion | 3.44 Billion |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | 5.2 Billion | 2.51 Billion | 4.62 Billion | 4.57 Billion | 4.3 Billion | 20.63 Million |
| Cost and Expenses | 34.5 Billion | 30.87 Billion | 28.77 Billion | 25.01 Billion | 22.73 Billion | 20.22 Billion |
| Operating Income | 1.77 Billion | 1.74 Billion | 1.53 Billion | 1.26 Billion | 1.24 Billion | 1.21 Billion |
| Interest Expense | 586 Million | 370.44 Million | 325.48 Million | 344.58 Million | 402.04 Million | 182.43 Million |
| Income Tax Expense | 364.09 Million | 389.18 Million | 337.12 Million | 253.29 Million | 240.64 Million | 291.04 Million |
| Earnings before Tax | 1.38 Billion | 1.41 Billion | 1.22 Billion | 940.94 Million | 868.84 Million | 1.05 Billion |
| Net Income | 984.48 Million | 1 Billion | 853.44 Million | 668.68 Million | 598.22 Million | 734.72 Million |
| Earnings Per Share Basic | 1.15 | 1.16 | 0.99 | 0.78 | 0.70 | 0.85 |
| Earnings Per Share Diluted | 1.15 | 1.16 | 0.99 | 0.78 | 0.70 | 0.85 |
| Weighted Average Shares Outstanding | 857.98 Million | 859.77 Million | 859.94 Million | 859.76 Million | 859.74 Million | 860.08 Million |
| Weighted Average Shares Outstanding (Diluted) | 858.11 Million | 860.36 Million | 860.41 Million | 859.76 Million | 859.74 Million | 860.09 Million |
| Gross Margin | 0.20 | 0.23 | 0.22 | 0.22 | 0.23 | 0.24 |
| EBIT Margin | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | 0.07 |
| Profit Margin | 0.03 | 0.03 | 0.03 | 0.03 | 0.02 | 0.03 |
| EBITDA | 2.98 Billion | 2.88 Billion | 2.49 Billion | 2.06 Billion | 1.89 Billion | 1.93 Billion |
| Earnings Before Tax Margin | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.06 |
| Breakdown | 2024 Q2 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Revenue | 19.56 Billion | 9.21 Billion | 36.28 Billion | 9.21 Billion | 17.85 Billion | 8.92 Billion |
| Cost of Revenue | 15.74 Billion | 7.09 Billion | 29.12 Billion | 7.09 Billion | 14.39 Billion | 6.93 Billion |
| Gross Profit | 3.81 Billion | 2.11 Billion | 7.15 Billion | 2.11 Billion | 3.45 Billion | 1.98 Billion |
| Operating Expenses | 2.78 Billion | 1.66 Billion | 5.25 Billion | 1.65 Billion | 2.58 Billion | 1.53 Billion |
| Selling, General and Administrative Expenses | 4.42 Billion | 618.12 Million | - | 618.12 Million | 4.04 Billion | - |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | 1.64 Billion | 1.04 Billion | 2.9 Billion | - | 1.46 Billion | - |
| Cost and Expenses | 18.52 Billion | 8.76 Billion | 34.38 Billion | 8.75 Billion | 16.97 Billion | 8.47 Billion |
| Operating Income | 1.03 Billion | 450.58 Million | 1.89 Billion | 450.58 Million | 876.74 Million | 439.03 Million |
| Interest Expense | 259.82 Million | 372.89 Million | 466.23 Million | - | 213.11 Million | - |
| Income Tax Expense | 215.65 Million | 90.43 Million | 364.09 Million | 90.43 Million | 183.22 Million | 91.61 Million |
| Earnings before Tax | 792.25 Million | 341.45 Million | 1.33 Billion | 341.45 Million | 677.18 Million | 350.83 Million |
| Net Income | 577.7 Million | 241.77 Million | 984.48 Million | 241.77 Million | 500.92 Million | 250.46 Million |
| Earnings Per Share Basic | 0.67 | 0.28 | - | 0.28 | 0.58 | 0.29 |
| Earnings Per Share Diluted | 0.67 | 0.28 | - | 0.28 | 0.58 | 0.29 |
| Weighted Average Shares Outstanding | 857.37 Million | 857.38 Million | 857.98 Million | 857.38 Million | 858.61 Million | 859.22 Million |
| Weighted Average Shares Outstanding (Diluted) | 858.17 Million | 857.54 Million | 858.11 Million | 857.54 Million | 858.68 Million | 858.68 Million |
| Gross Margin | 0.20 | 0.23 | 0.20 | 0.23 | 0.19 | 0.22 |
| EBIT Margin | 0.08 | 0.08 | - | 0.08 | 0.08 | 0.08 |
| Profit Margin | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 |
| EBITDA | 1.6 Billion | 721.37 Million | - | 721.37 Million | 1.39 Billion | 699.21 Million |
| Earnings Before Tax Margin | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 |
603956
EE
AXFOF
ORC-B
EMAX
6947